Recurrent guillain-barré syndrome following vaccination

Clinical Infectious Diseases

Volumn 54, Issue 6, 2012, Pages 800-804

  Baxter, Roge ^a   Lewis, Ned ^a   Bakshi, Nandini ^b   Vellozzi, Claudia ^c   Klein, Nicola P ^a  

^a KAISER PERMANENTE   (United States)

^b KAISER PERMANENTE MEDICAL CENTER   (United States)

^c CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DIPHTHERIA PERTUSSIS TETANUS VACCINE; HEPATITIS A VACCINE; HEPATITIS B VACCINE; INFLUENZA VACCINE; MEASLES MUMPS RUBELLA VACCINE; MENINGOCOCCUS VACCINE; PNEUMOCOCCUS VACCINE; POLIOMYELITIS VACCINE; TYPHOID VACCINE; VARICELLA ZOSTER VACCINE;

ADULT; AGED; ARTICLE; DIPHTHERIA; DRUG EXPOSURE; FEMALE; FOLLOW UP; GUILLAIN BARRE SYNDROME; HEPATITIS A; HEPATITIS B; HERPES ZOSTER; HUMAN; INFLUENZA; INFLUENZA VACCINATION; MAJOR CLINICAL STUDY; MALE; MEASLES; MENINGOCOCCOSIS; MUMPS; PERTUSSIS; PNEUMOCOCCAL INFECTION; POLIOMYELITIS; PRIORITY JOURNAL; RECURRENCE RISK; RECURRENT DISEASE; REVACCINATION; RUBELLA; TETANUS; TYPHOID FEVER; VACCINATION;

ADULT; AGED; CALIFORNIA; FEMALE; FOLLOW-UP STUDIES; GUILLAIN-BARRE SYNDROME; HUMANS; INCIDENCE; INFLUENZA VACCINES; MALE; MIDDLE AGED; RECURRENCE; TIME FACTORS; VACCINES; VACCINES, ATTENUATED; VACCINES, INACTIVATED;

EID: 84857519070     PISSN: 10584838     EISSN: 15376591     Source Type: Journal    
DOI: 10.1093/cid/cir960     Document Type: Article

References (36)

1. Newswanger DL, Warren CR. Guillain-Barre syndrome. Am Fam Physician 2004; 69:2405-10.
2. Joseph SA, Tsao CY. Guillain-Barre syndrome. Adolesc Med 2002; 13:487-94.
3. Klein NP, Ray P, Carpenter D, et al. Rates of autoimmune diseases in Kaiser Permanente for use in vaccine adverse event safety studies. Vaccine 2010; 28:1062-8.
4. Hughes RA, Rees JH. Clinical and epidemiologic features of Guillain- Barre syndrome. J Infect Dis 1997; 176(suppl 2):S92-8. (Pubitemid 27505868)
5. Hughes RA, Cornblath DR. Guillain-Barre syndrome. Lancet 2005; 366:1653-66.
6. Novak M. [Guillain-Barre syndrome as a sequela of influenza]. Cesk Neurol Neurochir 1975; 38:314-6.
7. Jacobs BC, Rothbarth PH, van der Meche FG, et al. The spectrum of antecedent infections in Guillain-Barre syndrome: a case-control study. Neurology 1998; 51:1110-5.
8. Newton N Jr, Janati A. Guillain-Barre syndrome after vaccination with purified tetanus toxoid. South Med J 1987; 80:1053-4. (Pubitemid 18048214)
9. Schonberger LB, Hurwitz ES, Katona P, Holman RC, Bregman DJ. Guillain-Barre syndrome: its epidemiology and associations with influenza vaccination. Ann Neurol 1981; 9(suppl):31-8. (Pubitemid 11120634)
10. Siddiqui A, Usmani RI, Anwer S, Afsar S. Guillain-Barre syndrome occurring after rabies vaccination. J Pak Med Assoc 2005; 55:87-8. (Pubitemid 40477003)
11. Tam CC, O'Brien SJ, Rodrigues LC. Influenza, Campylobacter and Mycoplasma infections, and hospital admissions for Guillain-Barre syndrome, England. Emerg Infect Dis 2006; 12:1880-7. (Pubitemid 44904926)
12. Hughes RA, Charlton J, Latinovic R, Gulliford MC. No association between immunization and Guillain-Barre syndrome in the United Kingdom, 1992 to 2000. Arch Intern Med 2006; 166:1301-4. (Pubitemid 43967583)
13. Roux X, Gramond C, De Greslan T, et al. [Guillain-Barre syndrome and anti-hepatitis A vaccination]. Med Mal Infect 2010; 40:490-2.
14. Kinnunen E, Farkkila M, Hovi T, Juntunen J,Weckstrom P. Incidence of Guillain-Barre syndrome during a nationwide oral poliovirus vaccine campaign. Neurology 1989; 39:1034-6. (Pubitemid 19217469)
15. Schonberger LB, Bregman DJ, Sullivan-Bolyai JZ, et al. Guillain-Barre syndrome following vaccination in the National Influenza Immunization Program, United States, 1976-1977. Am J Epidemiol 1979; 110:105-23.
16. Centers for Disease Control and Prevention. Preliminary results: surveillance for Guillain-Barre syndrome after receipt of influenza A (H1N1) 2009 monovalent vaccine-United States, 2009-2010. MMWR Morb Mortal Wkly Rep 2010; 59:657-61.
17. Green SK, Rett M, Weintraub ES, et al. Risk of confirmed Guillain- Barre Syndrome following monovalent inactivated influenza A (H1N1) and seasonal influenza vaccines in the Vaccine Safety Datalink Project, 2009-2010. Am J Epidemiol 2011; In press.
18. Centers for Disease Control and Prevention. Update: Guillain-Barre syndrome among recipients of Menactra meningococcal conjugate vaccine-United States, June 2005-September 2006. MMWR Morb Mortal Wkly Rep 2006; 55:1120-4.
19. Centers for Disease Control and Prevention. Update: Guillain-Barre syndrome among recipients of Menactra meningococcal conjugate vaccine-United States, October 2005-February 2006. MMWR Morb Mortal Wkly Rep 2006; 55:364-6.
20. Hughes R, Rees J, Smeeton N, Winer J. Vaccines and Guillain-Barre syndrome. BMJ 1996; 312:1475-6.
21. Schattner A. Consequence or coincidence? The occurrence, pathogenesis and significance of autoimmune manifestations after viral vaccines. Vaccine 2005; 23:3876-86. (Pubitemid 40726180)
22. Fiore AE, Uyeki TM, Broder K, et al. Prevention and control of influenza with vaccines: recommendations of the Advisory Committee on Immunization Practices (ACIP), 2010. MMWR Recomm Rep 2010; 59:1-62.
23. Smith NM, Bresee JS, Shay DK, Uyeki TM, Cox NJ, Strikas RA. Prevention and control of influenza: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep 2006; 55:1-42.
24. Barohn RJ, Saperstein DS. Guillain-Barre syndrome and chronic inflammatory demyelinating polyneuropathy. Semin Neurol 1998; 18: 49-61.
25. Pritchard J, Mukherjee R, Hughes RA. Risk of relapse of Guillain-Barre syndrome or chronic inflammatory demyelinating polyradiculoneuropathy following immunisation. J Neurol Neurosurg Psychiatry 2002; 73: 348-9. (Pubitemid 34953665)
26. Hughes RA, Choudhary PP, Osborn M, Rees JH, Sanders EA. Immunization and risk of relapse of Guillain-Barre syndrome or chronic inflammatory demyelinating polyradiculoneuropathy. Muscle Nerve 1996; 19:1230-1.
27. Seyal M, Ziegler DK, Couch JR. Recurrent Guillain-Barre syndrome following influenza vaccine. Neurology 1978; 28:725-6. (Pubitemid 8371513)
28. Pollard JD, Selby G. Relapsing neuropathy due to tetanus toxoid. Report of a case. J Neurol Sci 1978; 37:113-25. (Pubitemid 8350308)
29. Combes A, Goulon M. [Recurrence of Guillain-Barre syndrome]. Ann Med Interne (Paris) 1992; 143:515-8.
30. Krieger N. Overcoming the absence of socioeconomic data in medical records: validation and application of a census-based methodology. Am J Public Health 1992; 82:703-10.
31. Selby JV, Smith DH, Johnson ES, Raebel MA, Friedman GD, McFarland BH, eds. Kaiser Permanente medical care program. 4th ed. New York, NY: Wiley, 2005.
32. Greene SK, Shi P, Dutta-Linn MM, et al. Accuracy of data on influenza vaccination status at four Vaccine Safety Datalink sites. Am J Prev Med 2009; 37:552-5.
33. Sejvar JJ, Kohl KS, Gidudu J, et al. Guillain-Barre syndrome and Fisher syndrome: case definitions and guidelines for collection, analysis, and presentation of immunization safety data. Vaccine 2011; 29:599-612.
34. Ruts L, van Koningsveld R, van Doorn PA. Distinguishing acute-onset CIDP fromGuillain-Barre syndrome with treatment related fluctuations. Neurology 2005; 65:138-40. (Pubitemid 40967791)
35. Research criteria for diagnosis of chronic inflammatory demyelinating polyneuropathy (CIDP). Report from an ad hoc subcommittee of the American Academy of Neurology AIDS Task Force. Neurology 1991; 41:617-8.
36. Ruts L, Drenthen J, Jacobs BC, van Doorn PA. Distinguishing acuteonset CIDP from fluctuating Guillain-Barre syndrome: a prospective study. Neurology 2010; 74:1680-6.